Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01524874 · ClinicalTrials.gov registry record · NA

Comparative Effectiveness of Vitamin D and Repletion Strategies

A NA study, sponsored by Bastyr University.

Completed
Registry status
NA
Development phase
66
Enrollment target

NCT01524874 is a NA study that has completed, run by Bastyr University. The registered enrollment target is 66 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01524874, a NA study, has completed, sponsored by Bastyr University.

COMPLETED
Registry status
NA
Development phase
66 participants
Enrollment target

Study Summary

The importance of vitamin D (VitD) in the prevention and treatment of human health conditions has gained increased attention in recent years. As a result, medical providers of all categories are screening clinical VitD status frequently, yet become challenged with how to best advise patients regarding repletion of VitD status, i.e. which form of VitD replacement is most effective. It has been recognized that to achieve significant effects - serum concentrations \>30ng/ml (75 nmol/ml) - it is necessary, as well as safe, to recommend substantially higher doses than were previously thought sufficient. These higher doses can be easily achieved orally. This clinical trial aims to compare absorption of three available forms of this fat-soluble vitamin, due to the potential differences in absorption of different preparations. High-quality powdered, chewable and lipid-emulsified VitD are readily available as supplements, yet these have not been systematically compared. This three-arm, randomized clinical trial will compare the difference in serum 25-hydroxycholecalciferol (25-OH)D concentration between the three arms at baseline and after random administration of one of the three VitD preparations for 12-weeks at a dosage of 10,000 IU VitD per day. The investigators hypothesize that the three forms of vitD will result in an equivalent increase in serum 25OHD.

Interventions

  • DIETARY_SUPPLEMENT Vitamin D3

Trial Details

FieldValue
Enrollment Target 66 participants
Start Date 2010-08
Est. Completion 2011-11
Phase NA

Sponsor

Bastyr University

19 total trials

What the Registry Record Tells You About NCT01524874

The ClinicalTrials.gov registry entry for NCT01524874 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 66 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Bastyr University, which has 19 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Vitamin D3 is the first listed.

NCT01524874 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01524874 about?

NCT01524874 is a clinical study titled "Comparative Effectiveness of Vitamin D and Repletion Strategies". The importance of vitamin D (VitD) in the prevention and treatment of human health conditions has gained increased attention in recent years. As a result, medical providers of all categories are screening clinical VitD status frequently, yet become challenged with how to best advise patients regardi...

What is the current status of trial NCT01524874?

This trial is currently completed. It is a NA study. The enrollment target is 66 participants. The study started on 2010-08. Estimated completion is 2011-11.

What interventions are being tested in trial NCT01524874?

The interventions under investigation include: Vitamin D3 (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT01524874?

This trial is sponsored by Bastyr University, which has 19 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.